Trials / Withdrawn
WithdrawnNCT07008248
Real-World Clinical Study for Malignant Tumor-Induced Cachexia
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This study is a non-interventional, multicenter observational study, aiming to assess the clinical characteristics and treatment outcomes of malignant tumor cachexia. The study is mainly divided into two cohorts: Retrospective Cohort: This cohort focuses on patients who have already been diagnosed with cachexia before the initiation of this study. It involves the retrospective collection and analysis of clinical data. Prospective Cohort: This cohort includes patients who are diagnosed with cachexia after the start of this study. Data will be prospectively collected and analyzed during their subsequent diagnosis and treatment process.
Conditions
- Clinical Characteristics and Treatment Outcomes of Malignant Tumor Cachexia
- Multicenter Observational Study
Timeline
- Start date
- 2024-10-15
- Primary completion
- 2027-06-30
- Completion
- 2027-12-31
- First posted
- 2025-06-06
- Last updated
- 2025-08-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07008248. Inclusion in this directory is not an endorsement.